category,datetime,headline,id,image,related,source,summary,url
company,1769123490,Amgen (AMGN) Faces 340B Lawsuit: What Does Sagebrush Dispute Reveal About Its Stakeholder Strategy?,138219688,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,AMGN,Yahoo,"Sagebrush Health Services has filed a lawsuit in California state court accusing Amgen of unlawfully cutting off 340B discounted drug sales to its Nevada clinics and reclaiming at least US$7,000,000 in past discounts, allegedly disrupting care for low-income and uninsured patients. The case highlights growing legal and reputational risks around how drug makers interact with 340B “covered entities,” and whether manufacturers can effectively police program eligibility outside the federal...",https://finnhub.io/api/news?id=17338c66f7ad7dd948bc216826a3b3b04b95311b48e260f1be86b28dbb1f60f1
company,1769122802,Amgen (AMGN) Outpaces Stock Market Gains: What You Should Know,138220294,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,AMGN,Yahoo,"Amgen (AMGN) reached $347.07 at the closing of the latest trading day, reflecting a +1.01% change compared to its last close.",https://finnhub.io/api/news?id=3e1a7d53b51f8ae0a262b08fc95a6cf38e2537d2ee38843395847568e41d34fe
company,1769082300,"Procter & Gamble, 3M share gains lead Dow's nearly 450-point jump",138233081,,AMGN,MarketWatch,"Procter & Gamble, 3M share gains lead Dow's nearly 450-point jump",https://finnhub.io/api/news?id=faa8c21e6977f15ba474cd6a18d75e0240763a702b39e474c051bac16bd91799
company,1769080534,Amgen: A Buy In 2026 On Exciting MariTide Obesity - T2D Potential,138204949,,AMGN,SeekingAlpha,,https://finnhub.io/api/news?id=68c83ac8fef86632408b4d473d3ffee5ef4e9ef2da9e78f4b258b51eb957d844
